Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Jun 17, 2019
0
0
Canadian researchers followed their intuition that a drug initially intended for heart failure could be effective in treating cancer. Those efforts have borne fruit, as demonstrated by their work published in the Journal ...
Jun 12, 2019
0
2
Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) rapidly and effectively reduces pressure and volume in the heart. This is the first study targeting the SVC as a therapeutic ...
May 21, 2019
0
1
Dr. Tim Fenton, an expert in cancer research at the University, says the announcement of new strategies to overcome the evolution of drug resistance in tumours could dramatically increase the effectiveness of cancer therapies.
May 17, 2019
0
4
Researchers have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.
May 8, 2019
0
105
U.S. health authorities will allow a type of breast implant linked to a rare form of cancer to stay on the market, saying its risks do not warrant a national ban.
May 2, 2019
0
1
Surprisingly complex movements in an important neurotransmitter receptor may help explain the brain's unpredictable response to drugs, according to a new study. New research from an international team, published this week ...
Apr 30, 2019
0
17
The Emory Heart & Vascular Center is participating in an FDA-approved pivotal trial, called CALM-2 (Controlling And Lowering blood pressure with MobiusHDÒ), of a novel catheter-based, non-surgical procedure to treat patients ...
Apr 29, 2019
0
1
An estimated one in ten Australians were taking antidepressants in 2015. That's double the number using them in 2000, and the second-highest rate of antidepressant use among all OECD countries.
Apr 24, 2019
0
0
A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer ...
Apr 15, 2019
0
1
